81
49
Growth Score 81 in past quarter
-4 pts
Heat Score 49 in past quarter
11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
737228
PCT provides contract development and manufacturing services for cell therapy products.
Robert A. Preti: Founder /President & CEOPast Role: Hitachi Chemical, CEO
Lisata Therapeutics
About the Company
Progenitor Cell Therapy provides contract development and manufacturing services for cell therapy products. The company offers manufacturing solutions; engineering and innovation services; product and process development services; cell and tissue processing; storage, distribution, and delivery of tissues, primary cells, and cell therapy products;
and consulting and regulatory support services, such as product and process development, GTP/cGMP manufacturing, regulatory services, and business development and commercialization. It serves academic, biotech, pharmaceutical, and professional clients in the United States.
